Technical Analysis for ARVN - Arvinas, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 42.60 | -5.02% | -2.25 |
ARVN closed down 5.02 percent on Monday, March 18, 2024, on 1.13 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -5.02% | |
Pocket Pivot | Bullish Swing Setup | -5.02% | |
Bollinger Band Squeeze | Range Contraction | -5.02% |
Alert | Time |
---|---|
Down 5% | about 13 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Lower Bollinger Band Support | about 16 hours ago |
Down 3% | about 17 hours ago |
Fell Below Lower Bollinger Band | about 17 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/21/2024
Arvinas Inc. is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Disease Genetics Metabolism Chimera
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 53.08 |
52 Week Low | 13.57 |
Average Volume | 766,253 |
200-Day Moving Average | 29.50 |
50-Day Moving Average | 44.09 |
20-Day Moving Average | 46.57 |
10-Day Moving Average | 45.70 |
Average True Range | 2.58 |
RSI (14) | 40.12 |
ADX | 21.83 |
+DI | 15.96 |
-DI | 19.69 |
Chandelier Exit (Long, 3 ATRs) | 45.33 |
Chandelier Exit (Short, 3 ATRs) | 50.15 |
Upper Bollinger Bands | 49.80 |
Lower Bollinger Band | 43.33 |
Percent B (%b) | -0.11 |
BandWidth | 13.89 |
MACD Line | -0.15 |
MACD Signal Line | 0.54 |
MACD Histogram | -0.6823 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 46.55 | ||||
Resistance 3 (R3) | 46.92 | 45.97 | 45.89 | ||
Resistance 2 (R2) | 45.97 | 44.97 | 45.79 | 45.67 | |
Resistance 1 (R1) | 44.29 | 44.35 | 43.82 | 43.92 | 45.45 |
Pivot Point | 43.34 | 43.34 | 43.11 | 43.16 | 43.34 |
Support 1 (S1) | 41.66 | 42.34 | 41.19 | 41.29 | 39.75 |
Support 2 (S2) | 40.71 | 41.72 | 40.53 | 39.53 | |
Support 3 (S3) | 39.03 | 40.71 | 39.31 | ||
Support 4 (S4) | 38.66 |